EUVIMEDDescubrir EUVIMED
Crossref

White adipose tissue, a novel antirheumatic target: Clues from its secretory capability and adipectomy‐based therapy

Peng Ye, Qi-Hai Wang, Wen-Ye Kong, Chun-Sheng Liu, Dan-Dan Wang, Opeyemi Joshua Olatunji, Yan Li, Jian Zuo

British Journal of Pharmacology · 2024

DOI: 10.1111/bph.16360 ↗

At a glance

Journal article in British Journal of Pharmacology, 2024. Written by Peng Ye and 7 co-authors. Institution: Xin'an Medicine Research Center, The First Affiliated Hospital of Wannan Medical College (Yijishan Hospital), Wuhu, China. Major MEDLINE topics: Adipose Tissue, White, Arthritis, Experimental, Arthritis, Rheumatoid, PPAR gamma. Cited 10 times so far (Crossref); 48 references. Funded by: National Natural Science Foundation of China, Plans for Major Provincial Science & Technology Projects, Excellent Research and Innovation Team of Anhui Provincial Colleges.

ResumenSubjectsDatos bibliográficosCiteRelated studies

Abstract (original language)

Background and Purpose White adipose tissue (WAT) is involved in rheumatoid arthritis (RA). This study explored its potential as an antirheumatic target. Experimental Approach WAT status of healthy and adjuvant‐induced arthritis (AIA) rats were compared. The contribution of WAT to RA pathology was evaluated by pre‐adipocyte transplant experiments and by dissecting perirenal fat pads of AIA rats. The impact of RA on WAT was investigated by culturing pre‐adipocytes. Proteins differentially expressed in WAT of healthy and AIA rats were identified by the UPLC/MS 2 method. These together with PPARγ siRNA and agonist were used to treat pre‐adipocytes in vitro. The medium was used for THP‐1 monocyte culture. Key Results Compared with healthy controls, AIA WAT was smaller but secreted more leptin, eNAMPT, MCP‐1, TNF‐α, and IL‐6. AIA rat pre‐adipocytes increased the levels of these adipokines in healthy recipients. RA patients' serum induced a similar secretion change and impaired differentiation of pre‐adipocytes. Adipectomy eased AIA‐related immune abnormalities and arthritic manifestations. Hepatokines PON1, IGFBP4, and GPIHBP1 were among the differential proteins in high levels in RA blood, and induced inflammatory secretions by pre‐adipocytes. GPIHBP1 inhibited PPARγ expression and caused differentiation impairment and inflammatory secretion by pre‐adipocytes, a similar outcome to PPARγ‐silencing. This endowed the cells with an ability to activate monocytes, which can be abrogated by rosiglitazone. Conclusion and Implications Certain hepatokines potentiate inflammatory secretions by pre‐adipocytes and expedite RA progression by inhibiting PPARγ. Targeting this signalling or abnormal WAT secretion by various approaches may reduce RA severity.

Subjects

MeSH terms (MEDLINE)

Adipose Tissue, WhiteArthritis, ExperimentalArthritis, RheumatoidPPAR gammaAnimalsHumansRatsMaleAntirheumatic AgentsFemaleRats, Inbred LewAdipocytesAdipokines

Author keywords

GPIHBP1IGFBP4PON1adipocytesadipokinesadjuvant‐induced arthritisproteomics

Substances

PPAR gammaAntirheumatic AgentsAdipokines

Authors and institutions

  • Xin'an Medicine Research Center, The First Affiliated Hospital of Wannan Medical College (Yijishan Hospital), Wuhu, China.
  • Research Center of Integration of Traditional Chinese and Western Medicine, Wannan Medical College, Wuhu, China.
  • School of Pharmacy, Anhui College of Traditional Chinese Medicine, Wuhu, Anhui, China.
  • Department of Clinical Laboratory, The First Affiliated Hospital of Wannan Medical College (Yijishan Hospital), Wuhu, China.
  • African Genome Center, Mohammed VI Polytechnic University, Ben Guerir, Morocco.
  • Center for Xin'an Medicine and Modernization of Traditional Chinese Medicine, Institution of Health and Medicine, Hefei Comprehensive National Science Center, Hefei, China.

Funding

  • National Natural Science Foundation of China
  • Plans for Major Provincial Science & Technology Projects
  • Excellent Research and Innovation Team of Anhui Provincial Colleges
  • Key Projects of Wannan Medical College

Cite

APA

Ye, P., Wang, Q. H., Kong, W. Y., Liu, C. S., Wang, D. D., Olatunji, O. J., Li, Y., & Zuo, J. (2024). White adipose tissue, a novel antirheumatic target: Clues from its secretory capability and adipectomy‐based therapy. British Journal of Pharmacology. https://doi.org/10.1111/bph.16360

Vancouver

Ye P, Wang QH, Kong WY, Liu CS, Wang DD, Olatunji OJ, et al. White adipose tissue, a novel antirheumatic target: Clues from its secretory capability and adipectomy‐based therapy. British Journal of Pharmacology. 2024. doi:10.1111/bph.16360

BibTeX
@article{Ye2024,
  author = {Ye, Peng and Wang, Qi-Hai and Kong, Wen-Ye and Liu, Chun-Sheng and Wang, Dan-Dan and Olatunji, Opeyemi Joshua and Li, Yan and Zuo, Jian},
  title = {White adipose tissue, a novel antirheumatic target: Clues from its secretory capability and adipectomy‐based therapy},
  journal = {British Journal of Pharmacology},
  year = {2024},
  doi = {10.1111/bph.16360}
}
Start for free →